BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 15194118)

  • 1. Mu opioid receptor: a gateway to drug addiction.
    Contet C; Kieffer BL; Befort K
    Curr Opin Neurobiol; 2004 Jun; 14(3):370-8. PubMed ID: 15194118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mu-opioid receptor activation induces transcriptional plasticity in the central extended amygdala.
    Befort K; Filliol D; Ghate A; Darcq E; Matifas A; Muller J; Lardenois A; Thibault C; Dembele D; Le Merrer J; Becker JA; Poch O; Kieffer BL
    Eur J Neurosci; 2008 Jun; 27(11):2973-84. PubMed ID: 18588537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting endogenous mu- and delta-opioid receptor systems for the treatment of drug addiction.
    Shippenberg TS; LeFevour A; Chefer VI
    CNS Neurol Disord Drug Targets; 2008 Nov; 7(5):442-53. PubMed ID: 19128202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-nucleotide polymorphism (A118G) in exon 1 of OPRM1 gene causes alteration in downstream signaling by mu-opioid receptor and may contribute to the genetic risk for addiction.
    Deb I; Chakraborty J; Gangopadhyay PK; Choudhury SR; Das S
    J Neurochem; 2010 Jan; 112(2):486-96. PubMed ID: 19891732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mu opiate receptor gene dose effects on different morphine actions: evidence for differential in vivo mu receptor reserve.
    Sora I; Elmer G; Funada M; Pieper J; Li XF; Hall FS; Uhl GR
    Neuropsychopharmacology; 2001 Jul; 25(1):41-54. PubMed ID: 11377918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene.
    Matthes HW; Maldonado R; Simonin F; Valverde O; Slowe S; Kitchen I; Befort K; Dierich A; Le Meur M; Dollé P; Tzavara E; Hanoune J; Roques BP; Kieffer BL
    Nature; 1996 Oct; 383(6603):819-23. PubMed ID: 8893006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of G(i)alpha2-protein in opioid tolerance and mu-opioid receptor downregulation in vivo.
    Yoburn BC; Gomes BA; Rajashekara V; Patel C; Patel M
    Synapse; 2003 Feb; 47(2):109-16. PubMed ID: 12454948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lobeline, a potential pharmacotherapy for drug addiction, binds to mu opioid receptors and diminishes the effects of opioid receptor agonists.
    Miller DK; Lever JR; Rodvelt KR; Baskett JA; Will MJ; Kracke GR
    Drug Alcohol Depend; 2007 Jul; 89(2-3):282-91. PubMed ID: 17368966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compartment-specific localization of cannabinoid 1 (CB1) and mu-opioid receptors in rat nucleus accumbens.
    Pickel VM; Chan J; Kash TL; Rodríguez JJ; MacKie K
    Neuroscience; 2004; 127(1):101-12. PubMed ID: 15219673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoradiographic evidence that prenatal morphine exposure sex-dependently alters mu-opioid receptor densities in brain regions that are involved in the control of drug abuse and other motivated behaviors.
    Vathy I; Slamberová R; Rimanóczy A; Riley MA; Bar N
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):381-93. PubMed ID: 12691773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protracted abstinence from distinct drugs of abuse shows regulation of a common gene network.
    Le Merrer J; Befort K; Gardon O; Filliol D; Darcq E; Dembele D; Becker JA; Kieffer BL
    Addict Biol; 2012 Jan; 17(1):1-12. PubMed ID: 21955143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and functional significance of polymorphisms in the mu-opioid receptor gene (Oprm) promoter of C57BL/6 and DBA/2 mice.
    Doyle GA; Sheng XR; Schwebel CL; Ferraro TN; Berrettini WH; Buono RJ
    Neurosci Res; 2006 Jul; 55(3):244-54. PubMed ID: 16644048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphine-induced changes of gene expression in the brain.
    Ammon-Treiber S; Höllt V
    Addict Biol; 2005 Mar; 10(1):81-9. PubMed ID: 15849022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression is altered in the lateral hypothalamus upon activation of the mu opioid receptor.
    Befort K; Filliol D; Darcq E; Ghate A; Matifas A; Lardenois A; Muller J; Thibault C; Dembele D; Poch O; Kieffer BL
    Ann N Y Acad Sci; 2008; 1129():175-84. PubMed ID: 18591478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The RGSZ2 protein exists in a complex with mu-opioid receptors and regulates the desensitizing capacity of Gz proteins.
    Garzón J; Rodríguez-Muñoz M; López-Fando A; Sánchez-Blázquez P
    Neuropsychopharmacology; 2005 Sep; 30(9):1632-48. PubMed ID: 15827571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain regional Fos expression elicited by the activation of mu- but not delta-opioid receptors of the ventral tegmental area: evidence for an implication of the ventral thalamus in opiate reward.
    David V; Matifas A; Gavello-Baudy S; Decorte L; Kieffer BL; Cazala P
    Neuropsychopharmacology; 2008 Jun; 33(7):1746-59. PubMed ID: 17895918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid receptor regulation in mice.
    Yoburn BC; Billings B; Duttaroy A
    J Pharmacol Exp Ther; 1993 Apr; 265(1):314-20. PubMed ID: 8386239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphine withdrawal syndrome and its prevention with baclofen: Autoradiographic study of mu-opioid receptors in prepubertal male and female mice.
    Diaz SL; Barros VG; Antonelli MC; Rubio MC; Balerio GN
    Synapse; 2006 Aug; 60(2):132-40. PubMed ID: 16715492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphine mediates a proinflammatory phenotype via μ-opioid receptor-PKCɛ-Akt-ERK1/2 signaling pathway in activated microglial cells.
    Merighi S; Gessi S; Varani K; Fazzi D; Stefanelli A; Borea PA
    Biochem Pharmacol; 2013 Aug; 86(4):487-96. PubMed ID: 23796752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid peptide receptor studies. 16. Chronic morphine alters G-protein function in cells expressing the cloned mu opioid receptor.
    Xu H; Lu YF; Rothman RB
    Synapse; 2003 Jan; 47(1):1-9. PubMed ID: 12422367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.